Merck, Eisai Update Phase 3 LEAP-015 Trial for GE Adenocarcinoma
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eisai today announced results from the Phase 3 LEAP-015 trial evaluating...
Category : Healthcare and Pharmaceutical
Innate Pharma Doses First Patient in Phase 1 Study of IPH4502
IPH4502 is a novel and differentiated topoisomerase I inhibitor ADC conjugated to exatecan targeting Nectin-4 Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA)...
Sphere Fluidics Unveils Cyto-Mine Chroma, Early Access Open
Researchers invited to gain early access to next-generation platform to optimize functional single-cell analysis workflows across expanded applications in life science R&D Sphere Fluidics, a...
Ikonisys Wins U.S. Patent for Automated Cancer Treatment Analysis
Regulatory News: Ikonisys Inc., a leader in advanced cell-based diagnostic solutions fully owned by ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), is proud to announce the...
Corstasis Announces FDA Acceptance for Bumetanide Nasal Spray
PDUFA Target Action Date Set for September 14, 2025 Corstasis Therapeutics Inc. (www.corstasis.com), a clinical-stage MedTech pharmaceutical company developing innovative, practical therapies for fluid overload,...
Bamboo Health & Radial Partner to Enhance Value-Based Care
Centralizing more care at home with real-time identification and referrals Bamboo Health™, the leader in Real-Time Care Intelligence™, is teaming up with Radial, a pioneer in...
McKesson’s Practice Insights Named 2025 CMS QCDR
Designation enables providers to report meaningful, oncology-specific quality measures for participation in the Merit-based Incentive Payment System For the ninth consecutive year, the Centers for...
Caranx Medical Submits FDA Filing for TAVIPILOT Soft AI Software
Caranx Medical (“Caranx”), a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI),...
Elion Launches Report on AI Clinician Copilots and Scribe Tools
Leading healthcare IT research and vendor marketplace, Elion, announced today the release of its latest report, “AI Clinician Copilots: Technology, Market Trends, and Key Differentiators.” This in-depth...
eClinicalWorks AI Tools Boost Patient Care at Springfield Family
32-provider Springfield Family Physicians harnesses the power of Sunoh.ai and eClinicalWorks Image AI to streamline operations and improve patient care eClinicalWorks®, the largest ambulatory cloud...
Systech Unveils Semi-Automated Aggregation Solution for Pharma
Systech, part of Markem-Imaje and Dover and a leading provider of digital identification and traceability software solutions, today announced the introduction of the ST16 Semi-Automated Multi-Aggregation Station for pharmaceutical...
GC Cell-Bifarma Symposium Expands Immuncell-LC’s Global Reach
GC Cell, a leading cell and gene therapy company, announced the successful completion of its first thought leadership symposium in Jakarta, Indonesia. The event was organized...
Kelun-Biotech’s Tagitanlimab Approved for NPC First-Line Treatment
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company“) announced that the Company received marketing authorization in China from National Medical Products Administration (NMPA) for the programmed cell death ligand...
Datar Cancer Genetics Launches Tumor-Agnostic MRD Blood Test
The Target-MRD blood test uses a combination of tumor-informed and tumor-agnostic molecular features for personalized, accurate and more effective monitoring of molecular residual disease. Datar...
Breakthrough Study Shows MatriDerm® Superior in Wound Healing
MatriDerm® by MedSkin Solutions Dr. Suwelack AG Proven to Enhance Cell Activity, Reduce Inflammation, and Deliver Better Wound Healing Outcomes in Research Study MedSkin Solutions...